Lipogranulomas of the mammary glands: diagnosis and treatment
DOI:
https://doi.org/10.52692/1857-0011.2021.2-70.25Keywords:
mammary gland, lipogranuloma, carcinoma, necrosisAbstract
Steatonecrosis of the mammary gland is necrosis of its adipose tissue, followed by replacement with scar tissue. Lipogranuloma is known as a benign inflammatory process, necrosis of breast fat occurs due to iatrogenic breast trauma. Most often, fatty necrosis is seen in women with large breasts – in women with small breasts, it develops much less often. It is important to diagnose lipogranulomas because it can often mimic breast cancer. Fat necrosis of the breast is a common pathological condition, with a wide variety of presentations on mammography, ultrasound and MRI. The incidence of fatty necrosis of the breast is estimated at 0.6%, representing 2.75% of all breast lesions
References
International Agency for Research on Cancer. GLOBOCAN 2018: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2018. [accesat la 2.08.2019].
Protocolul Clinic Național PCN-102 „Cancerul glandei mamare” din 23.01.2020.
Kuerer H.M., Smith B.D., Chavez-MacGregor M., et al. DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes. J Cancer. 2017;8(14):2653-2662.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) – Breast Cancer. Version 3.2018 — October 25, 2018.
Mereuță I., Gațcan Șt. Mastopațiile difuze. Chișinău. Print-Caro; 2012.
Peltecu Gh. Cancer mamar. Ghid clinic pentru Obstetrică şi Ginecologie. Societatea de Obstetrică şi Ginecologie din România. Colegiul Medicilor din România. Tipografia AuroPrint; 2019.
Sayed A.H., Edi B., Frederick C., Korner P., Peter R. Rosen’s Breast Pathology. Fourth Edition. New York. HC-Printed Cover; 2014.
Abu-Helalah M.A., Alshraideh H.A., Al-Serhan A.A., et al. Knowledge, barriers and attitudes towards breast cancer mamography screening in jordan. Asian Pac J Cancer Prev. 2015; 16: 3981-90.
Autier P., Boniol M., Koechlin A., Pizot C., Boniol M. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. BMJ. 2017; 359: 5224.
Bakker M.F., De Lange S.V., Pijnappel R.M. et al. The DENSE Trial Study Group. Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med. 2019; 381(22): 2091-2102.
Berg W.A., Zhang Z., Lehrer D. et al. For the ACRIN 6666 Investigators. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012; 307(13): 1394-404.
Bernardi D., Macaskill P., Pellegrini M. et al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016; 17(8): 1105-13.
Bolejko A., Hagell P., Wann-Hansson C., Zackrisson S. Prevalence, long-term development, and predictors of psychosocial consequences of false-positive mammography among women attending population-based screening. Cancer Epidemiol Biomarkers Prev. 2015; 24(9): 1388-97.
Botnariuc N. Factorii de pronostic în tratamentul cancerului glandei mamare în stadiul I. Teză de doctor în ştiinţe medicale. 2010; 112.
Chiarelli A.M., Prummel M.V., Muradali D. et al. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the Ontario High Risk Breast Screening Program. J Clin Oncol. 2014;32(21):2224-30.
Choi B.H., Choi N., Kim M.Y., Yang J.H., Yoo Y.B., Jung H.K. Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery. Breast Cancer Res Treat. 2018; 167(2): 495-502.
Cotruţă A. Particularități clinico-biologice ale cancerului glandei mamare la bolnavele în menopauză. Teză de doctor în ştiinţe medicale. Chişinău. 2013; 173.
Duric N., Boyd N., Littrup P. et al. Breast density measurements with ultrasound tomography: a comparison with film and digital mammography. Med Phys. 2013; 40(1): 013501.
Ghidirim N., Sofroni L., Bacalîm L., Corobcean O., Tcaciuc D. Investigaţiile clinico-morfologice şi imunohistochimice ale bolnavilor de cancer mamar faza reproductivă în perioada preoperatorie. Arta. 2015; 3(56): 157-158.
Sofroni L. Cancerul glandei mamare – maladia întregii civilizații. Buletinul Academiei de Ştiinţe a Moldovei. 2018; 2-3(59-60): 132-137.
Chiaburu S. Aprecierea tacticii de tratament intraoperator al carcinomului neinvaziv mamar în dependent de datele clinice, imagistice şi morfologice. Buletinul Academiei de Ştiinţe a Moldovei. 2013; 4(40): 73-76.
Sofroni L., Tcaciuc D., Badan A., Jovmir V., Machidon V., Cotruţa A., et al. Conduita preoperatorie la pacientele cu cancer a glandei mamare şi diabet zaharat tip 2. Buletinul Academiei de Ştiinţe a Moldovei. 2015; 3(48): 178-182.
Centrul Medical de Diagnostic şi Tratament Dr. Victor Babes. Mamografia. Disponibil la: https:// www.cdt-babes.ro/articole/mamografia.php [accesat la 12.06.2019].
ESMO GHID. Cancerul Mamar. Disponibil la: https://www.esmo.org/content/download/300499/5990632/1/RO-Cancerul-de-San-Ghid-pentru-Pacienti.pdf [accesat la 05.02.2018].
Protocolul Clinic Național. PCN-102 Cancerul glandei mamare 2019. Disponibil la: https://msmps.gov.md/wp-content/uploads/2020/07/11860-tfjfggg.pdf [accesat la 03.05.2020].
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
